Recent studies unveil the heterogeneity and dynamics of CD8+ T cells in cancer and chronic viral infections, including TCF1– effector-like cells that upregulate expression of TIM-325,26 (encoded by Havcr2). The gene discussed is CD8A; the disease is cancer.